ARMP

Quote

Short

News

Articles

Message Board

Armata Pharmaceuticals Inc. (NYSE : ARMP ) News

Armata Pharmaceuticals Inc. (NYSE: ARMP) News Releases

ARMP News Releases

March 13, 2026 09:55:05 am

SeekingAlpha

Small-Cap healthcare stocks ranked by quant ratings after earnings season

March 12, 2026 03:39:54 pm

SeekingAlpha

Armata Pharmaceuticals: Intriguing Antibiotic Adjunct, But Too Many Potential Red Flags

February 23, 2026 07:00:00 am

PR Newswire

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02

January 13, 2026 07:42:00 am

PR Newswire

/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./

January 13, 2026 07:00:00 am

PR Newswire

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus

November 18, 2025 07:00:00 am

PR Newswire

Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST

November 13, 2025 12:47:14 am

SeekingAlpha

Armata Pharmaceuticals GAAP EPS of -$0.74, revenue of $1.16M

November 12, 2025 04:05:00 pm

PR Newswire

Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update

November 10, 2025 07:00:00 am

PR Newswire

Armata Pharmaceuticals Announces Formal Commissioning of State-of-the-Art cGMP Phage Manufacturing Facility in Los Angeles, California

October 31, 2025 03:11:24 pm

SeekingAlpha

Catalyst Watch - Tesla holder vote on Musk pay; AMD, Palantir earnings

Back to Start	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account